• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
  • Newsroom
    • Scientific Publications
    • Press Releases
    • Events
  • Partnering
  • Investors
    • Overview
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us

4th International Conference on Lymphocyte Engineering (Munich, Sep 12-14)

August 17, 2023 Caroline Lonez

Our lead scientists Jennifer Bolsée and Matteo Rossi will provide an update on our NKG2D-based multi-specific CAR T-cells and multiplex shRNA platform at the ICLE 2023 conference poster session in Munich.

If you want to know more about our platforms and CAR T-cell candidates, come to see their poster and discuss with them!

 

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Newsroom
  • Partnering
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2026 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use